Interleukin-10 regulates TNF-α-converting enzyme (TACE/ADAM-17) involving a TIMP-3 dependent and independent mechanism

European Journal of Immunology

Volumn 38, Issue 4, 2008, Pages 1106-1117

  Brennan, Fionula M ^a   Green, Patricia ^a   Amjadi, Parisa ^a   Robertshaw, Heidi J ^a   Alvarez Iglesias, Montserrat ^b   Takata, Masao ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

IL 10; Inflammation; TNF; TNF converting enzyme

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ADAM PROTEIN; ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANTIBODY PRODUCTION; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EX VIVO STUDY; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; MOLECULAR MECHANICS; MONOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; CATALYSIS; CELL CULTURE; CELL MEMBRANE; CONFOCAL MICROSCOPY; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; SOLUBILITY; UPREGULATION;

ADAM PROTEINS; ANTIBODIES; CATALYSIS; CELL MEMBRANE; CELLS, CULTURED; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MICROSCOPY, CONFOCAL; MONOCYTES; SOLUBILITY; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 44849131435     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737821     Document Type: Article

References (48)

1. Feldmann, M., Brennan, F. M. and Maini, R. N., Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 1996. 14: 397-440.
2. Feldmann, M. and Maini, R. N., Anti-TNF-α therapy or rheumatoid arthritis: What have we learned? Annu. Rev. Immunol. 2001. 19: 163-196.
3. Tang, P., Hung, M. C. and Klostergaard, J., Human pro-tumor necrosis factor is a homotrimer. Biochemistry 1996. 35: 8216-8225.
4. Black, R. A., Ranch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J. et al., A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997. 385: 729-733.
5. Moss, M. L., Jin, S. L., Milla, M. E., Bickett, D. M., Burkhart, W., Carter, H. L., Chen, W. J. et al., Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997. 385: 733-736.
6. Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E. et al., An essential role for ectodomain shedding in mammalian development. Science 1998. 282: 1281-1284.
7. Slack, B. E., Ma, L. K. and Seah, C. C., Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme. Biochem. J. 2001. 357: 787-794.
8. Althoff, K., Reddy, P., Voltz, N., Rose-John, S. and Mullberg, J., Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. Eur. J. Biochem. 2000. 267: 2624-2631.
9. Tsakadze, N. L., Sithu, S. D., Sen, U., English, W. R., Murphy, G. and D'Souza, S. E., Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). J. Biol. Chem. 2006. 281: 3157-3164.
10. Doedens, J. R. and Black, R. A., Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 2000. 275: 14598-14607.
11. Brew, K., Dinakarpandian, D. and Nagase, H., Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim. Biophys. Acta 2000. 1477: 267-283.
12. Blenis, J. and Hawkes, S. P., Characterization of a transformation-sensitive protein in the extracellular matrix of chicken embryo fibroblasts. J. Biol. Chem. 1984. 259: 11563-11570.
13. Bond, M., Murphy, G., Bennett, M. R., Amour, A., Knauper, V., Newby, A. C. and Baker, A. H., Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity. J. Biol. Chem. 2000. 275: 41358-41363.
14. Amour, A., Slocombe, P. M., Webster, A., Butter, M., Knight, C. G., Smith, B. J., Stephens, P. E. et al., TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 1998. 435: 39-44.
15. Lee, M. H., Knauper, V., Becherer, J. D. and Murphy, G., Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase. Biochem Biophys. Res. Commun. 2001. 280: 945-950.
16. Su, S., Grover, J., Roughley, P. J., DiBattista, J. A., Martel-Pelletier, J. Pelletier, J. P. and Zafarullah, M., Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatol. Int. 1999. 18: 183-191.
17. Takizawa, M., Ohuchi, E., Yamanaka, H., Nakamura, H., Ikeda, E., Ghosh, P. and Okada, Y., Production of tissue inhibitor of metalloproteinases 3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts. Arthritis. Rheum. 2000. 43: 812-820.
18. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P. and Mosmann, T. R., Interleukin-10. Annu. Rev. Immunol. 1993. 11: 165-190.
19. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M. and O'Garra, A., IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991. 147: 3815-3822.
20. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. and O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001. 19: 683-765.
21. Joyce, D. A., Gibbons, D., Green, P., Feldmann, M. and Brennan, F. M., Two inhibitors of pro-inflammatory cytokine release, IL-10 and IL-4, have contrasting effects on release of soluble p75 TNF receptor by cultured monocytes. Eur. J. Immunol. 1994. 24: 2699-2705.
22. Williams, L. M., Ricchetti, G., Sarma, U., Smallie, T. and Foxwell, B. M., Interleukin-10 suppression of myeloid cell activation-a continuing puzzle. Immunology 2004. 113: 281-292.
23. Wang, P., Wu, P., Siegel, M. I., Egan, R. W. and Billah, M. M., IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 1994. 153: 811-816.
24. Wang, P., Wu, P., Siegel, M. I., Egan, R. W. and Billah, M. M., Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and ILA suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 1995. 270: 9558-9563.
25. Shames, B. D., Selzman, C. H., Meldrum, D.R., Pulido, E. J., Barton, H. A., Meng, X., Harken, A. H. and McIntyre, R. C., Jr., Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. Shock 1998. 10: 389-394.
26. Schottelius, A. J., Mayo, M. W., Sartor, R. B. and Baldwin, A. S., Jr., Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J. Biol. Chem. 1999. 274: 31868-31874.
27. Murray, P. J., The primary mechanism of the IL-10-regulated anti-inflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA 2005. 102: 8686-8691.
28. Clarke, C. J., Hales, A., Hunt, A. and Foxwell, B. M., IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. Eur. J. Immunol. 1998. 28: 1719-1726.
29. Kontoyiannis, D., Kotlyarov, A., Carballo, E., Alexopoulou, L., Blackshear, P. J., Gaestel, M., Davis, R. et al., Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J. 2001. 20: 3760-3770.
30. Denys, A., Udalova, I. A., Smith, C., Williams, L. M., Ciesielski, C. J., Campbell, J., Andrews, C. et al., Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages. J. Immunol. 2002. 168: 4837-4845.
31. Kuwata, H., Watanabe, Y., Miyoshi, H., Yamamoto, M., Kaisho, T., Takeda, K. and Akira, S., IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 2003. 102: 4123-4129.
32. Zhou, L., Nazarian, A. A. and Smale, S. T., Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway. Mol. Cell. Biol. 2004. 24: 2385-2396.
33. Qasimi, P., Ming-Lum, A., Ghanipour, A., Ong, C. J., Cox, M. E., Ihle, J., Cacalano, N. et al., Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophages. J. Biol. Chem. 2006. 281: 6316-6324.
34. Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Forster, I. and Akira, S., Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999. 10: 39-49.
35. Williams, L., Bradley, L., Smith, A. and Foxwell, B., Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 2004. 172: 567-576.
36. Alvarez-Iglesias, M., Wayne, G., O'Dea, K. P., Amour, A. and Takata, M., Continuous real-time measurement of tumor necrosis factor-alpha converting enzyme activity on live cells. Lab. Invest. 2005. 85: 1440-1448.
37. Wetzel, M., Rosenberg, G. A. and Cunningham, L. A., Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur. J. Neurosci. 2003. 18: 1050-1060.
38. Bzowska, M., Jura, N., Lassak, A., Black, R. A. and Bereta, J., Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells. Eur. J. Biochem. 2004. 271: 2808-2820.
39. Lacraz, S., Nicod, L. P., Chicheportiche, R., Welgus, H. G. and Dayer, J. M., IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J. Clin. Invest. 1995. 96: 2304-2310.
40. Foey, A. D., Parry, S. L., Williams, L.M., Feldmann, M., Foxwell, B. M. and Brennan, F. M., Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF- alpha: Role of the p38 and p42/44 mitogen-activated protein kinases. J. Immunol. 1998. 160: 920-928.
41. Katsikis, P. D., Chu, C. Q., Brennan, F. M.,Maini, R. N. and Feldmann, M., Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 1994. 179: 1517-1527.
42. Hermann, J. A., Hall, M. A., Maini, R. N., Feldmann, M. and Brennan, F. M., Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis. Arthritis Rheum. 1998. 41: 1388-1397.
43. Mahmoodi, M., Sahebjam, S., Smookler, D., Khokha, R. and Mort, J. S., Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. Am. J. Pathol. 2005. 166: 1733-1740.
44. Tang, Z. Y., Loss, G., Carmody, I. and Cohen, A. J., TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats. Transplantation 2006. 82: 1518-1523.
45. Mohammed, F. F., Smookler, D. S., Taylor, S. E., Fingleton, B., Kassiri, Z., Sanchez, O. H., English, J. L. et al., Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat. Genet. 2004. 36: 969-977.
46. Kashiwagi, M., Tortorella, M., Nagase, H. and Brew, K., TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J. Biol. Chem. 2001. 276: 12501-12504.
47. Itoh, Y., Ito, A., Iwata, K., Tanzawa, K., Mori, Y. and Nagase, H., Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. J. Biol. Chem. 1998. 273: 24360-24367.
48. Brennan, F. M., Hayes, A. L., Ciesielski, C. J., Green, P., Foxwell, B. M. J. and Feldmann, M., Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells. Arthritis Rheum. 2002. 46: 31-41.